Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Safest stablecoins in 2026 balance resilience, reserve quality, and regulatory alignment. This primer outlines evaluation criteria.
15,106 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Investors are weighing Alibaba's AI and cloud ambitions against profits and regulatory headwinds. This guide breaks d...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
Caterpillar's backlog hits a record, fueling optimism that shares could approach $1,000 by 2027. Analysts weigh upsid...
XRP is tightening within a narrow range as Bollinger Bands compress, sparking expectations of a major move. Analysts ...
Geopolitical tensions flare as Iran hints at escalation. The crypto suffers iran threatens mood weighs on Bitcoin and...
Three under-the-radar high-yield ETFs are delivering higher income in a market where cash yields rise. This report br...
A surprising White House appearance between political rivals marks a new chapter in the fight over drug prices, with ...
The debt tally has climbed to $39 trillion, with daily additions near $5 billion. Economists warn the path could cons...
A de-extinction startup says it hatched 26 live chicks in a lab using a synthetic eggshell, spotlighting frontier bio...
S&P Global is evolving beyond ratings into a comprehensive financial infrastructure platform. Learn why this shift ma...
Thinking long term pays off in the stock market. This guide reveals three growth stock archetypes you can buy and hol...